Nath Bio-Genes (India) Limited (NATHBIOGEN) - Total Assets
Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) holds total assets worth Rs10.97 Billion INR (≈ $118.68 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nath Bio-Genes (India) Limited - Total Assets Trend (2012–2026)
This chart illustrates how Nath Bio-Genes (India) Limited's total assets have evolved over time, based on quarterly financial data. Also see market value of Nath Bio-Genes (India) Limited for the company's overall valuation and market capitalisation.
Nath Bio-Genes (India) Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Nath Bio-Genes (India) Limited's total assets of Rs10.97 Billion consist of 71.0% current assets and 29.0% non-current assets. Review Nath Bio-Genes (India) Limited debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 6.9% |
| Accounts Receivable | Rs854.15 Million | 7.8% |
| Inventory | Rs4.51 Billion | 41.1% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs55.86 Million | 0.5% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2012–2026)
This chart illustrates how Nath Bio-Genes (India) Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Nath Bio-Genes (India) Limited for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nath Bio-Genes (India) Limited's current assets represent 71.0% of total assets in 2026, a decrease from 80.2% in 2012.
- Cash Position: Cash and equivalents constituted 6.9% of total assets in 2026, up from 2.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 41.1% of total assets.
Nath Bio-Genes (India) Limited Competitors by Total Assets
Key competitors of Nath Bio-Genes (India) Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥61.57 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486
|
China | CN¥18.71 Billion |
|
Guangxi Hechi Chemical Co Ltd
SHE:000953
|
China | CN¥272.22 Million |
|
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556
|
China | CN¥11.55 Billion |
|
Zuari Agro Chemicals Limited
NSE:ZUARI
|
India | Rs40.76 Billion |
|
Minbos Resources Ltd
AU:MNB
|
Australia | AU$36.78 Million |
|
Insumos Agroquimicos SA
BA:INAG
|
Argentina | AR$45.35 Billion |
Nath Bio-Genes (India) Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 1.89 | 3.03 |
| Quick Ratio | 0.83 | 0.96 | 1.72 |
| Cash Ratio | 0.00 | 0.24 | 0.00 |
| Working Capital | Rs3.84 Billion | Rs3.25 Billion | Rs3.51 Billion |
Nath Bio-Genes (India) Limited - Advanced Valuation Insights
This section examines the relationship between Nath Bio-Genes (India) Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.47 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.9% |
| Total Assets | Rs10.97 Billion |
| Market Capitalization | $30.28 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nath Bio-Genes (India) Limited's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nath Bio-Genes (India) Limited's assets grew by 6.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nath Bio-Genes (India) Limited (2012–2026)
The table below shows the annual total assets of Nath Bio-Genes (India) Limited from 2012 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs10.97 Billion ≈ $118.68 Million |
+6.94% |
| 2025-03-31 | Rs10.26 Billion ≈ $110.98 Million |
+16.58% |
| 2024-03-31 | Rs8.80 Billion ≈ $95.19 Million |
+11.03% |
| 2023-03-31 | Rs7.93 Billion ≈ $85.74 Million |
+6.86% |
| 2022-03-31 | Rs7.42 Billion ≈ $80.23 Million |
-6.03% |
| 2021-03-31 | Rs7.90 Billion ≈ $85.38 Million |
+8.16% |
| 2020-03-31 | Rs7.30 Billion ≈ $78.94 Million |
+12.98% |
| 2019-03-31 | Rs6.46 Billion ≈ $69.87 Million |
+13.11% |
| 2018-03-31 | Rs5.71 Billion ≈ $61.77 Million |
+97.41% |
| 2017-03-31 | Rs2.89 Billion ≈ $31.29 Million |
+8.49% |
| 2016-03-31 | Rs2.67 Billion ≈ $28.84 Million |
+17.93% |
| 2015-03-31 | Rs2.26 Billion ≈ $24.46 Million |
+19.07% |
| 2014-03-31 | Rs1.90 Billion ≈ $20.54 Million |
+19.99% |
| 2013-03-31 | Rs1.58 Billion ≈ $17.12 Million |
+31.95% |
| 2012-03-31 | Rs1.20 Billion ≈ $12.97 Million |
-- |
About Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; plant nutrient supplements; pearl millets; seeds for field crops, such as bajra, maize, corn, paddy, wheat, and jow… Read more